
|Articles|November 15, 2002
Innovating Information
Boise, Idaho - The most significant impact of information therapy on a dermatology practice will be extending the doctor's office into the patient's home, said Donald W. Kemper, chief executive officer of Healthwise, Inc., a healthcare decision-making company. Several years ago Kemper coined "information therapy," or "Ix." The term refers to the provision of current, evidence-based information to patients and their caregivers at each step of diagnosis and treatment.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
5











